302 related articles for article (PubMed ID: 16844380)
1. Synthesis and structure activity relationships of novel non-peptidic metallo-aminopeptidase inhibitors.
Albrecht S; Defoin A; Salomon E; Tarnus C; Wetterholm A; Haeggström JZ
Bioorg Med Chem; 2006 Nov; 14(21):7241-57. PubMed ID: 16844380
[TBL] [Abstract][Full Text] [Related]
2. Amino-benzosuberone: a novel warhead for selective inhibition of human aminopeptidase-N/CD13.
Albrecht S; Al-Lakkis-Wehbe M; Orsini A; Defoin A; Pale P; Salomon E; Tarnus C; Weibel JM
Bioorg Med Chem; 2011 Feb; 19(4):1434-49. PubMed ID: 21292493
[TBL] [Abstract][Full Text] [Related]
3. Rapid and efficient synthesis of a novel series of substituted aminobenzosuberone derivatives as potent, selective, non-peptidic neutral aminopeptidase inhibitors.
Albrecht S; Salomon E; Defoin A; Tarnus C
Bioorg Med Chem; 2012 Aug; 20(16):4942-53. PubMed ID: 22796349
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of amino-hydroxy-benzocycloheptenones as potent, selective, non-peptidic dinuclear zinc metalloaminopeptidase inhibitors.
Al-Lakkis-Wehbe M; Chaillou B; Defoin A; Albrecht S; Tarnus C
Bioorg Med Chem; 2013 Nov; 21(21):6447-55. PubMed ID: 24055078
[TBL] [Abstract][Full Text] [Related]
5. A library of novel hydroxamic acids targeting the metallo-protease family: design, parallel synthesis and screening.
Flipo M; Beghyn T; Charton J; Leroux VA; Deprez BP; Deprez-Poulain RF
Bioorg Med Chem; 2007 Jan; 15(1):63-76. PubMed ID: 17070058
[TBL] [Abstract][Full Text] [Related]
6. Novel 3-amino-2-hydroxy acids containing protease inhibitors. Part 1: Synthesis and kinetic characterization as aminopeptidase P inhibitors.
Stöckel-Maschek A; Stiebitz B; Koelsch R; Neubert K
Bioorg Med Chem; 2005 Aug; 13(16):4806-20. PubMed ID: 15993089
[TBL] [Abstract][Full Text] [Related]
7. Novel cyclic-imide peptidomimetics as aminopeptidase N inhibitors. Design, chemistry and activity evaluation. Part I.
Li Q; Fang H; Wang X; Hu L; Xu W
Eur J Med Chem; 2009 Dec; 44(12):4819-25. PubMed ID: 19683842
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the aminopeptidase from Aeromonas proteolytica by aliphatic alcohols. Characterization of the hydrophobic substrate recognition site.
Ustynyuk L; Bennett B; Edwards T; Holz RC
Biochemistry; 1999 Aug; 38(35):11433-9. PubMed ID: 10471294
[TBL] [Abstract][Full Text] [Related]
9. alpha-Aminoalkylphosphonates as a tool in experimental optimisation of P1 side chain shape of potential inhibitors in S1 pocket of leucine- and neutral aminopeptidases.
Drag M; Grembecka J; Pawełczak M; Kafarski P
Eur J Med Chem; 2005 Aug; 40(8):764-71. PubMed ID: 16122579
[TBL] [Abstract][Full Text] [Related]
10. The synthesis and preliminary activity assay in vitro of peptide-like derivatives as APN inhibitors.
Li SH; Li G; Huang HM; Xiong F; Liu CM; Tu GG
Arch Pharm Res; 2008 Oct; 31(10):1231-9. PubMed ID: 18958412
[TBL] [Abstract][Full Text] [Related]
11. Aeromonas proteolytica aminopeptidase: an investigation of the mode of action using a quantum mechanical/molecular mechanical approach.
Schürer G; Lanig H; Clark T
Biochemistry; 2004 May; 43(18):5414-27. PubMed ID: 15122907
[TBL] [Abstract][Full Text] [Related]
12. Novel cyclic-imide peptidomimetics as aminopeptidase N inhibitors. Structure-based design, chemistry and activity evaluation. II.
Li Q; Fang H; Wang X; Xu W
Eur J Med Chem; 2010 Apr; 45(4):1618-26. PubMed ID: 20129718
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of 1,3,4-thiadiazole derivatives as aminopeptidase N inhibitors.
Li SH; Li G; Huang HM; Xiong F; Mai X; Kuang BH; Liu CM; Tu GG
Pharmazie; 2009 Feb; 64(2):67-70. PubMed ID: 19320275
[TBL] [Abstract][Full Text] [Related]
14. Identification of potent type I MetAPs inhibitors by simple bioisosteric replacement. Part 2: SAR studies of 5-heteroalkyl substituted TCAT derivatives.
Cui YM; Huang QQ; Xu J; Chen LL; Li JY; Ye QZ; Li J; Nan FJ
Bioorg Med Chem Lett; 2005 Sep; 15(18):4130-5. PubMed ID: 16005224
[TBL] [Abstract][Full Text] [Related]
15. Effect of several amino acid phosphonates and other compounds on rat brain and kidney peptidases.
Weiss B; Hui KS; Benuck M; Hui M; Berg MJ; Lajtha A
Res Commun Chem Pathol Pharmacol; 1986 Apr; 52(1):81-92. PubMed ID: 3520730
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.
Liu Y; Shang L; Fang H; Zhu H; Mu J; Wang Q; Wang X; Yuan Y; Xu W
Bioorg Med Chem; 2009 Oct; 17(20):7398-404. PubMed ID: 19782572
[TBL] [Abstract][Full Text] [Related]
17. Ionic immobilization, diversification, and release: application to the generation of a library of methionine aminopeptidase inhibitors.
Vedantham P; Guerra JM; Schoenen F; Huang M; Gor PJ; Georg GI; Wang JL; Neuenswander B; Lushington GH; Mitscher LA; Ye QZ; Hanson PR
J Comb Chem; 2008; 10(2):185-94. PubMed ID: 18163595
[TBL] [Abstract][Full Text] [Related]
18. Novel matrix metalloproteinase inhibitors derived from quinoxalinone scaffold (Part I).
Li Y; Zhang J; Xu W; Zhu H; Li X
Bioorg Med Chem; 2010 Feb; 18(4):1516-25. PubMed ID: 20097082
[TBL] [Abstract][Full Text] [Related]
19. 1-Butaneboronic acid binding to Aeromonas proteolytica aminopeptidase: a case of arrested development.
De Paola CC; Bennett B; Holz RC; Ringe D; Petsko GA
Biochemistry; 1999 Jul; 38(28):9048-53. PubMed ID: 10413478
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of beta-amino-alpha-hydroxy amide derivatives as inhibitors of MetAP2 and HUVEC growth.
Sendzik M; Janc JW; Cabuslay R; Honigberg L; Mackman RL; Magill C; Squires N; Waldeck N
Bioorg Med Chem Lett; 2004 Jun; 14(12):3181-4. PubMed ID: 15149671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
